Sunesis Pharmaceuticals Company Profile (NASDAQ:SNSS)

About Sunesis Pharmaceuticals

Sunesis Pharmaceuticals, Inc. is a biopharmaceutical company. The Company focuses on the development and commercialization of its pipeline of oncology therapeutics for the treatment of solid and hematologic cancers. The Company offers QINPREZO (vosaroxin), which is a product candidate for the treatment of acute myeloid leukemia (AML). Vosaroxin is an anticancer quinolone derivative (AQD). The Company's other kinase inhibitor pipeline include TAK-580, SNS-062 and SNS-229. TAK-580 is an oral, investigative drug selective for pan-Raf kinase inhibition, in patients with relapsed or refractory solid tumors. SNS-062 is a non-covalently binding inhibitor of Bruton's tyrosine kinase (BTK). The Company has completed the pre-clinical studies for SNS-062. SNS-229 and SNS-510 are two PDK1 inhibitors. PDK1 is a kinase and mediator of Phosphoinositide 3-kinase/AKT (PI3K/AKT) signaling, which is a pathway involved in cell growth, differentiation, survival and migration.

Industry, Sector and Symbol:

• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: Biotechnology
• Exchange: NASDAQ
• Symbol: SNSS
• CUSIP: 86732860

Key Metrics:

• Previous Close: $4.44
• 50 Day Moving Average: $4.49
• 200 Day Moving Average: $3.55
• 52-Week Range: $14,502,000.00 - $2.64
• Trailing P/E Ratio: N/A
• Foreward P/E Ratio: -2.07
• P/E Growth: -0.01
• Market Cap: $64.39M
• Outstanding Shares: 14,502,000
• Beta: 1.77

Profitability:

• Net Margins: -1,503.34%
• Return on Equity: -806.43%
• Return on Assets: -102.31%

Debt:

• Current Ratio: 3.26%
• Quick Ratio: 3.26%

Additional Links:

• Visit Sunesis Pharmaceuticals' Official Website
• View SNSS on Google Finance
• View SNSS on Yahoo Finance
• View SNSS's Company Profile on Reuters
• Search for Sunesis Pharmaceuticals Inc. on Google

Companies Related to Sunesis Pharmaceuticals:

• Alcobra (NASDAQ:ADHD)
• Merus Labs International (NASDAQ:MSLI)
• Pain Therapeutics (NASDAQ:PTIE)
• OncoCyte Corp. (NYSEMKT:OCX)
• Trillium Therapeutics (NASDAQ:TRIL)
• VolitionRX Ltd (NYSEMKT:VNRX)
• Vivus (NASDAQ:VVUS)
• ArQule (NASDAQ:ARQL)
• Mirati Therapeutics (NASDAQ:MRTX)
• Zynerba Pharmaceuticals (NASDAQ:ZYNE)

Earnings

Earnings History for Sunesis Pharmaceuticals (NASDAQ:SNSS)

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call	Details
11/3/2016
7/29/2016	Q216	($0.10)	($0.12)	$0.70 million	$0.60 million	View	Listen
5/5/2016	Q116	($0.12)	($0.12)	$0.77 million	$0.64 million	View	Listen
3/10/2016	Q415	($0.14)	($0.15)	$0.84 million	$0.67 million	View	Listen
11/5/2015	Q315	($0.12)	($0.09)	$1.09 million	$0.68 million	View	Listen
7/30/2015	Q215	($0.13)	($0.15)	$1.21 million	$0.85 million	View	N/A
5/5/2015	Q115	($0.16)	($0.13)	$1.14 million	$0.90 million	View	Listen
3/12/2015	Q414	($0.20)	($0.02)	$1.17 million	$0.90 million	View	Listen
11/10/2014	Q314	($0.17)	($0.25)	$1.97 million	$0.85 million	View	Listen
8/5/2014	Q214	($0.17)	($0.20)	$1.32 million	$2.00 million	View	Listen
5/7/2014	Q114	($0.17)	($0.26)	$1.32 million	$2.00 million	View	Listen
3/6/2014	Q413	($0.20)	($0.15)	$1.37 million	$2.00 million	View	Listen
11/12/2013	Q313	($0.20)	($0.16)	$1.44 million	$1.99 million	View	Listen
7/29/2013	Q2 2013	($0.21)	$0.18	$1.22 million	$1.99 million	View	Listen
5/9/2013	Q1 2013	($0.20)	($0.23)	$0.75 million	$1.99 million	View	Listen
3/13/2013	Q4 2012	($0.19)	($0.20)	$0.32 million	$1.99 million	View	Listen
11/8/2012	Q312	($0.11)	($0.37)	$4.17 million	$0.26 million	View	N/A
8/9/2012		($0.20)	($0.20)			View	N/A
5/15/2012		($0.18)	($0.30)			View	N/A
11/14/2011		($0.18)	($0.11)			View	N/A
8/11/2011		($0.15)	($0.18)			View	N/A

(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Sunesis Pharmaceuticals (NASDAQ:SNSS)

Dividends

Dividend History for Sunesis Pharmaceuticals (NASDAQ:SNSS)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Sunesis Pharmaceuticals (NASDAQ:SNSS)

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Details
5/26/2016	Geoffrey M Parker	Director	Buy	9,500	$0.47	$4,465.00
5/25/2016	Geoffrey M Parker	Director	Buy	52,505	$0.47	$24,677.35
12/21/2015	Dayton Misfeldt	Director	Buy	1,750,000	$0.84	$1,470,000.00
8/25/2015	Daniel N Swisher Jr	CEO	Buy	12,216	$1.01	$12,338.16
8/24/2015	Daniel N Swisher Jr	CEO	Buy	12,784	$1.01	$12,911.84
8/29/2014	Forest Baskett	Major Shareholder	Sell	266,700	$7.97	$2,125,599.00
8/28/2014	Bay City Capital Llc	Major Shareholder	Sell	300,700	$7.98	$2,399,586.00
8/28/2014	Dayton Misfeldt	Director	Sell	200,000	$7.89	$1,578,000.00
8/27/2014	Adam R Craig	CMO	Sell	2,554	$8.00	$20,432.00
8/27/2014	Daniel N Swisher Jr	CEO	Sell	5,000	$8.00	$40,000.00
8/27/2014	Dayton Misfeldt	Director	Sell	100,700	$8.16	$821,712.00
8/27/2014	Eric Bjerkholt	CFO	Sell	10,000	$8.00	$80,000.00
8/27/2014	Krishna Kittu Kolluri	Major Shareholder	Sell	108,300	$8.17	$884,811.00
8/12/2014	Dayton Misfeldt	Director	Sell	743,700	$6.64	$4,938,168.00
8/12/2014	Equity Opportunities Fu Growth	Major Shareholder	Sell	710,540	$6.63	$4,710,880.20

(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Sunesis Pharmaceuticals (NASDAQ:SNSS)

Date	Headline
	Sunesis Pharmaceuticals : Announces 1-for-6 Reverse Stock Split (NASDAQ:SNSS) www.4-traders.com - September 25 at 12:40 PM
	Sunesis Pharmaceuticals : to Present at Upcoming Investor Conferences (NASDAQ:SNSS) www.4-traders.com - September 24 at 11:43 AM
	What are Research Firms Saying About Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS)? - Frisco Fastball (NASDAQ:SNSS) friscofastball.com - September 19 at 11:55 AM
	SUNESIS PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits (NASDAQ:SNSS) biz.yahoo.com - September 12 at 6:55 PM
	Sunesis Presents Dose Escalation Results from the Phase 1A Healthy Volunteer Study Evaluating Oral Non-Covalent BTK inhibitor SNS-062 (NASDAQ:SNSS) www.publicnow.com - September 12 at 12:05 PM
	Sunesis Pharmaceuticals, Inc. Preliminary Results From the Oral Non-Covalent BTK-inhibitor SNS-062 Call scheduled for 8:00 am ET today (NASDAQ:SNSS) biz.yahoo.com - September 12 at 12:05 PM
	Stock Stepping Up to a Recent High: Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) - Post News (NASDAQ:SNSS) www.kentuckypostnews.com - September 9 at 6:59 PM
	What are Analysts Expecting for Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) Earnings? - Frisco Fastball (NASDAQ:SNSS) friscofastball.com - September 9 at 6:59 PM
	ETF’s with exposure to Sunesis Pharmaceuticals, Inc. : September 9, 2016 (NASDAQ:SNSS) www.capitalcube.com - September 9 at 12:09 PM
	Biotech Stocks Worth Chasing: Sunesis Pharmaceuticals, Inc ... - The Independent Republic (NASDAQ:SNSS) theindependentrepublic.com - September 8 at 7:02 PM
	Sunesis Pharmaceuticals Announces 1-for-6 Reverse Stock Split - GlobeNewswire (press release) (NASDAQ:SNSS) www.globenewswire.com - September 8 at 7:02 PM
	Sunesis Pharmaceuticals (SNSS) Files for One-for-Six Reverse Stock Split - StreetInsider.com (NASDAQ:SNSS) www.streetinsider.com - September 7 at 7:30 PM
	Sunesis Pharmaceuticals Announces 1-for-6 Reverse Stock Split (NASDAQ:SNSS) www.publicnow.com - September 7 at 7:30 PM
	SUNESIS PHARMACEUTICALS INC Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Fina (NASDAQ:SNSS) biz.yahoo.com - September 7 at 7:30 PM
	Sunesis Pharmaceuticals (SNSS) Announces Presentation of SNS-062 Phase 1a Data (NASDAQ:SNSS) www.streetinsider.com - September 1 at 7:20 PM
	Sunesis Pharmaceuticals (SNSS) Announces Presentation of SNS-062 Phase 1a Data - StreetInsider.com (NASDAQ:SNSS) www.streetinsider.com - September 1 at 10:36 AM
	Sunesis Pharmaceuticals Announces Poster Presentation on Preliminary Results from the Phase 1A Healthy Volunteer Study Evaluating Oral Non-Covalent BTK-inhibitor SNS-062 at the European School of Haematology’s 2nd International Conference o (NASDAQ:SNSS) www.publicnow.com - September 1 at 10:36 AM
	Sunesis to Present at Upcoming Investor Conferences (NASDAQ:SNSS) www.publicnow.com - August 31 at 12:47 PM
	$ESV & $SNSS - ENSCO PLC (NYSE:ESV) & Sunesis Pharmaceuticals, (NASDAQ:SNSS) Intraday Movers - Money News (press release) (NASDAQ:SNSS) www.newsismoney.com - August 29 at 7:19 PM
	Sunesis Announces Publication in "Drugs" Detailing Molecular and Pharmacologic Properties of Vosaroxin (NASDAQ:SNSS) www.publicnow.com - August 25 at 12:35 PM
	Will Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) Hit $2.5 Price Target? - Investor Newswire (NASDAQ:SNSS) www.investornewswire.com - August 19 at 10:25 AM
	Sunesis Pharmaceuticals, Inc.'s (SNSS): Stock's Report of the Thursday - Hot Stocks Point (NASDAQ:SNSS) www.hotstockspoint.com - August 19 at 10:25 AM
	ETF’s with exposure to Sunesis Pharmaceuticals, Inc. : August 18, 2016 (NASDAQ:SNSS) www.capitalcube.com - August 18 at 7:45 PM
	Trading the Biotech News: Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS), ContraVir Pharmaceuticals, Inc. (NASDAQ ... - The Voice Registrar (NASDAQ:SNSS) voiceregistrar.com - August 18 at 10:35 AM
	Sunesis Pharmaceuticals (SNSS) Jumps: Stock Rises 23.1% (NASDAQ:SNSS) finance.yahoo.com - August 18 at 10:35 AM
	SUNESIS PHARMACEUTICALS INC Financials (NASDAQ:SNSS) finance.yahoo.com - August 5 at 7:44 PM
	ETF’s with exposure to Sunesis Pharmaceuticals, Inc. : August 4, 2016 (NASDAQ:SNSS) www.capitalcube.com - August 4 at 7:58 PM
	Sunesis Pharmaceuticals, Inc. :SNSS-US: Earnings Analysis: Q2, 2016 By the Numbers : August 3, 2016 (NASDAQ:SNSS) www.capitalcube.com - August 3 at 7:53 PM
	Upbeat Biotech Stocks- Sunesis Pharmaceuticals (NASDAQ:SNSS), CytRx Corporation (NASDAQ:CYTR) - Seneca Globe (NASDAQ:SNSS) www.senecaglobe.com - August 2 at 12:28 PM
	Technical Evaluation For Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) - The Voice Registrar (NASDAQ:SNSS) voiceregistrar.com - August 2 at 12:28 PM
	Does Sunesis Pharmaceuticals, Inc. (NASDAQ: SNSS) Have Sufficient Cash To Remain Afloat? - Scibility Media (NASDAQ:SNSS) scibilitymedia.com - August 2 at 12:28 PM
	Sunesis Pharmaceuticals Inc. (SNSS) Jumps 7.56% on August 01 - Equities.com (NASDAQ:SNSS) www.equities.com - August 1 at 7:17 PM
	Edited Transcript of SNSS earnings conference call or presentation 29-Jul-16 3:00pm GMT (NASDAQ:SNSS) finance.yahoo.com - August 1 at 7:16 PM
	Beatable Stocks in Active Notes- Alphabet (NASDAQ:GOOG), Sunesis Pharmaceuticals (NASDAQ:SNSS), Wellesley ... - Seneca Globe (NASDAQ:SNSS) www.senecaglobe.com - August 1 at 12:08 PM
	HC Stocks Newsbeat: Epirus Biopharmaceuticals Inc (NASDAQ:EPRS) Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) - share market updates (press release) (NASDAQ:SNSS) sharemarketupdates.com - August 1 at 12:08 PM
	Traders Recap: Sunesis Pharmaceuticals, Inc. (SNSS), CSX Corp. (CSX), Eclipse Resources Corporation (ECR) - iStreetWire (NASDAQ:SNSS) istreetwire.com - August 1 at 12:08 PM
	United Parcel Service, (NYSE:UPS) & Sunesis Pharmaceuticals, (NASDAQ:SNSS) Stock's Buzzers - Money News (press release) (NASDAQ:SNSS) www.newsismoney.com - August 1 at 12:08 PM
	Cowen Comments on Sunesis Pharmaceuticals, Inc. (SNSS) Following 2Q:16 Update - Smarter Analyst (NASDAQ:SNSS) www.smarteranalyst.com - July 31 at 11:20 AM
	Sunesis Pharmaceuticals Inc. (SNSS) Jumps 28.44% on July 29 - Equities.com (NASDAQ:SNSS) www.equities.com - July 30 at 10:14 AM
	7:04 am Sunesis Pharma misses by $0.02, misses on revs (NASDAQ:SNSS) finance.yahoo.com - July 30 at 7:04 AM
	Sunesis Pharmaceuticals Inc.: Sunesis Pharmaceuticals Reports Second Quarter 2016 Financial Results and Recent Highlights (NASDAQ:SNSS) www.twst.com - July 29 at 7:41 PM
	Sunesis Pharmaceuticals Reports Second Quarter 2016 Financial Results and Recent Highlights (NASDAQ:SNSS) www.nasdaq.com - July 29 at 10:35 AM
	Sunesis Pharmaceuticals : reports 2Q loss (NASDAQ:SNSS) www.4-traders.com - July 29 at 10:35 AM
	Sunesis reports 2Q loss (NASDAQ:SNSS) sg.finance.yahoo.com - July 29 at 9:18 AM
	Stock Moving Lower for the Month; Investor Update on Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) - Engelwood Daily (NASDAQ:SNSS) www.engelwooddaily.com - July 22 at 10:24 AM
	Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily (NASDAQ:SNSS) www.engelwooddaily.com - July 22 at 10:24 AM
	Is $2.5 Price Target Attainable For Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS)? - Investor Newswire (NASDAQ:SNSS) www.investornewswire.com - July 22 at 10:24 AM
	Equity Roundup: Stock Performance Focus on Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) - Press Telegraph (NASDAQ:SNSS) presstelegraph.com - July 22 at 10:24 AM
	Sunesis Pharmaceuticals Inc (NASDAQ:SNSS) Stock Technicals at Critical Inflection Point - CML News (NASDAQ:SNSS) news.cmlviz.com - July 22 at 10:24 AM
	Insiders Increasing Positions in: Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) - Press Telegraph (NASDAQ:SNSS) presstelegraph.com - July 21 at 10:19 AM

Social

Sunesis Pharmaceuticals (NASDAQ:SNSS) Chart for Monday, September, 26, 2016